Align Technology Expects to Repurchase $200M Worth of Stock Over Next 6 Months

Dow Jones
Apr 30

By Elias Schisgall

 

Align Technology expects to repurchase $200 million worth of stock over the next six months.

The medical technology company said Wednesday that the new buybacks will begin on May 1. The company ended March with $800 million available for buybacks under its $1 billion buyback authorization, after repurchasing $200 million in stock between August 2025 and January.

Align reported a first-quarter profit of $112.8 million, or $1.57 a share, compared with a profit of $93.2 million, or $1.27 a share, a year earlier.

On an adjusted basis, earnings were $2.58 a share. Analysts polled by FactSet were expecting $2.29 a share.

Revenue rose 6.2% to $1.04 billion, ahead of analyst estimates of $1.02 billion, according to FactSet.

The company said it has yet to see any material impacts on its results in Europe, the Middle East, and Asia from the war in Iran, but that it is monitoring developments and is assuming some impact in the second quarter.

It said it does not expect any material impacts on its results from President Trump's new Section 122 tariffs.

For the current second quarter, the company said it expects revenue between $1.04 billion and $1.06 billion. Analysts are expecting $1.06 billion in revenue.

The company reaffirmed its full-year outlook for revenue growth between 3% and 4%.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

April 29, 2026 19:23 ET (23:23 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10